Dozee Validation for Contactless Heart Rate and Respiration Monitoring in Clinical Settings
Condition(s) studied
Investigational drug(s) / intervention(s)
Telemetry monitoring: All participants will be on standard telemetry monitoring for Heart Rate, Respiration Rate and movements using the gold standard (Electrocardiography and Capnography respectively)
Study summary
The Dozee VS system (K221555) is a contactless device that tracks heart rate and breathing rate using a sensor sheet placed under the mattress. It captures body vibrations and converts them into vital signs, which can be monitored remotely in real time. The system also supports add-ons like a blood pressure cuff, pulse oximeter, and thermometer, offering a complete monitoring solution. This study aims to validate the updated AI-powered heart rate and improved breathing rate algorithms across different sensor sheet types to confirm clinical accuracy
Eligibility
Primary outcome measure(s)
- Mean Absolute Error (MAE) of Dozee's Heart Rate a from the Gold Standard ECG — 6 months
Heart Rate collected at 1 Min intervals from gold standard and Dozee. Mean Absolute Error (MAE) of the Dozee Heart Rate will be calculated - Mean Absolute Error (MAE) of Dozee's Respiratory Rate from the Gold Standard Capnography — 6 months
Respiratory Rate collected at 1 Min intervals from gold standard and Dozee. Mean Absolute Error (MAE) of the Dozee Respiratory Rate will be calculated.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Oak Village Healthcare | Lake Jackson | Texas | Recruiting |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07735403 on ClinicalTrials.gov ↗ ← All trials in the USA